Resultado de búsqueda
View the profiles of people named Greg Mckee. Join Facebook to connect with Greg Mckee and others you may know. Facebook gives people the power to share...
3 de feb. de 2021 · Following his appointment to the Board of Directors in January, Tryp Therapeutics has now appointed Greg McKee as Executive Chairman. McKee has a great deal of experience in the biotech industry and associated capital markets, which bears resemblance to the nascent psychedelics space.
3 de feb. de 2021 · La Jolla, California-- (Newsfile Corp. - February 3, 2021) - Tryp Therapeutics (CSE: TRYP) ("Tryp"), a leading pharmaceutical company focused on identifying and developing clinical-stage compounds...
Mr. McKee has more than 20 years of biotechnology, life sciences management and leadership and venture investment experience. Before joining Tryp , he founded Torrent Ventures, an early stage digital health and medical technology venture fund, and served as chief executive officer of CONNECT, the largest Southern California start-up accelerator ...
3 de feb. de 2021 · Mr. McKee joined the Board in January of 2021 and brings more than 20 years of biotechnology, life sciences management and venture investment experience to the company.
Most recently, Mr. McKee spent significant time supporting early stage life science and digital health companies as CEO of CONNECT, an early stage incubator, and as Managing Director at Torrent Ventures. He was previously appointed as Chairman of the Board of Directors of Tryp in February 2021.
McKee began his life science career at Genzyme where he was responsible for commercializing leading compounds for rare diseases throughout Asia. He then served as Chairman and CEO of Nventa Biopharmaceuticals Corporation and Akela Pharma Inc., both publicly traded biopharmaceutical companies.
